Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Hypoglossal nerve stimulator shows promise for treating sleep apnea in children with Down syndrome August 5, 2025 What are the effects of smoking cessation on vascular endothelial function? October 16, 2023 Frequent ultra-processed food consumption raises mortality risks, especially in women October 22, 2024
Hypoglossal nerve stimulator shows promise for treating sleep apnea in children with Down syndrome August 5, 2025
Frequent ultra-processed food consumption raises mortality risks, especially in women October 22, 2024